GRANDE ALICIA
Insider CIK 1402652 · CPRX VP, Treasurer and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 8,666 | — | $0 | 1,187,168 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 8,666 | — | $0 | 59,223 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-12-27 | 2023-12-29 | 3,410 | — | $0 | 55,813 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-11 | 2023-12-12 | 60,000 | — | $0 | 1,195,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-11 | 2023-12-12 | 60,000 | $1.13 | $67.8K | 110,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-12-11 | 2023-12-12 | 30,000 | $13.74 | $412.2K | 80,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-12-11 | 2023-12-12 | 30,000 | $13.79 | $413.7K | 50,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-08 | 2023-12-12 | 40,000 | — | $0 | 1,255,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-12-08 | 2023-12-12 | 20,000 | $14.25 | $285.0K | 70,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-12-08 | 2023-12-12 | 20,000 | $14.30 | $286.0K | 50,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-08 | 2023-12-12 | 40,000 | $1.13 | $45.2K | 90,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-03-29 | 2023-03-30 | 50,000 | — | $0 | 1,295,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-29 | 2023-03-30 | 20,000 | $16.70 | $334.0K | 60,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-29 | 2023-03-30 | 20,000 | $16.72 | $334.4K | 80,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-03-29 | 2023-03-30 | 50,000 | $1.13 | $56.5K | 100,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-29 | 2023-03-30 | 10,000 | $16.67 | $166.7K | 50,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-03-28 | 2023-03-30 | 58,216 | — | $0 | 1,345,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-03-28 | 2023-03-30 | 58,216 | $0.79 | $46.0K | 108,773 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-28 | 2023-03-30 | 28,216 | $16.60 | $468.4K | 80,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-28 | 2023-03-30 | 10,000 | $16.37 | $163.7K | 50,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-28 | 2023-03-30 | 10,000 | $16.52 | $165.2K | 60,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-28 | 2023-03-30 | 10,000 | $16.55 | $165.5K | 70,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-03-22 | 2023-03-24 | 38,524 | — | $0 | 1,404,050 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-03-22 | 2023-03-24 | 3,260 | — | $0 | 1,442,574 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-03-22 | 2023-03-24 | 38,524 | $0.79 | $30.4K | 89,081 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-03-22 | 2023-03-24 | 3,260 | $0.79 | $2.6K | 53,817 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-22 | 2023-03-24 | 3,260 | $16.41 | $53.5K | 50,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-22 | 2023-03-24 | 38,524 | $16.51 | $636.0K | 50,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 11,166 | — | $0 | 1,445,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 11,166 | — | $0 | 53,275 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-02-15 | 2023-02-17 | 2,718 | — | $0 | 50,557 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 26,000 | — | $0 | 1,457,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 88,000 | — | $0 | 1,431,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-12-06 | 2022-12-08 | 14,667 | — | $0 | 1,343,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-12-06 | 2022-12-08 | 14,667 | — | $0 | 42,109 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-22 | 2022-11-23 | 120,000 | $16.53 | $1.98M | 27,442 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-15 | 2022-11-17 | 60,000 | $15.77 | $946.2K | 147,442 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-23 | 2022-09-26 | 60,000 | $11.90 | $714.0K | 207,442 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-16 | 2022-09-20 | 90,000 | $13.50 | $1.22M | 267,442 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-14 | 2022-09-16 | 50,000 | $15.57 | $778.5K | 357,442 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-29 | 2022-08-30 | 17,000 | $14.28 | $242.8K | 407,442 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-29 | 2022-08-30 | 20,000 | $14.14 | $282.8K | 444,442 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-29 | 2022-08-30 | 20,000 | $14.20 | $284.0K | 424,442 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-26 | 2022-08-30 | 11,095 | $14.40 | $159.8K | 464,442 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-18 | 2022-08-19 | 19,259 | — | $0 | 1,357,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-18 | 2022-08-19 | 19,259 | $13.70 | $263.8K | 475,537 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-18 | 2022-08-19 | 19,259 | $2.53 | $48.7K | 494,796 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-17 | 2022-08-19 | 31,425 | — | $0 | 1,376,926 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-17 | 2022-08-19 | 99,316 | — | $0 | 1,408,351 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-17 | 2022-08-19 | 31,425 | $2.53 | $79.5K | 506,962 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-17 | 2022-08-19 | 99,316 | $2.53 | $251.3K | 574,853 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-17 | 2022-08-19 | 99,316 | $13.85 | $1.38M | 475,537 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-17 | 2022-08-19 | 31,425 | $13.87 | $435.9K | 475,537 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 33,500 | — | $0 | 1,507,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 167,500 | — | $0 | 1,474,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-12-03 | 2021-12-06 | 14,667 | — | $0 | 1,306,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-12-03 | 2021-12-06 | 14,667 | — | $0 | 479,108 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2021-12-03 | 2021-12-06 | 3,571 | — | $0 | 475,537 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-08-18 | 2021-08-19 | 70,000 | — | $0 | 1,321,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-08-18 | 2021-08-19 | 70,000 | $3.12 | $218.4K | 477,441 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2021-08-18 | 2021-08-19 | 13,000 | $5.68 | $73.8K | 464,441 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-08-17 | 2021-08-19 | 100,000 | — | $0 | 1,391,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-08-17 | 2021-08-19 | 100,000 | $3.12 | $312.0K | 507,441 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2021-08-17 | 2021-08-19 | 100,000 | $5.67 | $567.0K | 407,441 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-30 | 2021-01-04 | 250,000 | — | $0 | 1,491,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2020-12-22 | 2020-12-23 | 14,666 | — | $0 | 1,241,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2020-12-22 | 2020-12-23 | 14,666 | — | $0 | 411,012 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2020-12-22 | 2020-12-23 | 3,571 | — | $0 | 407,441 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 44,000 | — | $0 | 1,256,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 132,000 | — | $0 | 1,212,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 75,000 | — | $0 | 930,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 75,000 | — | $0 | 1,005,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 75,000 | — | $0 | 1,080,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 95,000 | — | $0 | 665,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 95,000 | — | $0 | 855,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 95,000 | — | $0 | 760,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2017-11-06 | 2017-11-07 | 200,000 | — | $0 | 270,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2017-11-06 | 2017-11-07 | 200,000 | $0.47 | $94.0K | 396,346 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 770,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 720,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 670,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 50,000 | — | $0 | 710,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 50,000 | — | $0 | 660,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 50,000 | — | $0 | 610,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 50,000 | — | $0 | 560,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 50,000 | — | $0 | 510,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2015-08-25 | 2015-08-26 | 40,000 | — | $0 | 460,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2015-08-25 | 2015-08-26 | 40,000 | $1.09 | $43.6K | 196,346 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise deriv | 2014-10-02 | 2014-10-03 | 90,000 | — | $0 | 500,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise | 2014-10-02 | 2014-10-03 | 90,000 | $0.90 | $81.0K | 156,346 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 56,667 | — | $0 | 590,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 56,666 | — | $0 | 476,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 56,667 | — | $0 | 533,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 66,667 | — | $0 | 368,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 66,667 | — | $0 | 435,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 66,666 | — | $0 | 301,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-07-03 | 2012-07-05 | 18,000 | $0.55 | $9.9K | 66,346 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-07-03 | 2012-07-05 | 2,000 | $0.54 | $1.1K | 48,346 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-05-30 | 2012-05-31 | 17,300 | $0.57 | $9.9K | 46,346 | SEC↗ |